HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention

Rebecca F Baggaley, Richard G White, Marie-Claude Boily, Rebecca F Baggaley, Richard G White, Marie-Claude Boily

Abstract

Background: The human immunodeficiency virus (HIV) infectiousness of anal intercourse (AI) has not been systematically reviewed, despite its role driving HIV epidemics among men who have sex with men (MSM) and its potential contribution to heterosexual spread. We assessed the per-act and per-partner HIV transmission risk from AI exposure for heterosexuals and MSM and its implications for HIV prevention.

Methods: Systematic review and meta-analysis of the literature on HIV-1 infectiousness through AI was conducted. PubMed was searched to September 2008. A binomial model explored the individual risk of HIV infection with and without highly active antiretroviral therapy (HAART).

Results: A total of 62,643 titles were searched; four publications reporting per-act and 12 reporting per-partner transmission estimates were included. Overall, random effects model summary estimates were 1.4% [95% confidence interval (CI) 0.2-2.5)] and 40.4% (95% CI 6.0-74.9) for per-act and per-partner unprotected receptive AI (URAI), respectively. There was no significant difference between per-act risks of URAI for heterosexuals and MSM. Per-partner unprotected insertive AI (UIAI) and combined URAI-UIAI risk were 21.7% (95% CI 0.2-43.3) and 39.9% (95% CI 22.5-57.4), respectively, with no available per-act estimates. Per-partner combined URAI-UIAI summary estimates, which adjusted for additional exposures other than AI with a 'main' partner [7.9% (95% CI 1.2-14.5)], were lower than crude (unadjusted) estimates [48.1% (95% CI 35.3-60.8)]. Our modelling demonstrated that it would require unreasonably low numbers of AI HIV exposures per partnership to reconcile the summary per-act and per-partner estimates, suggesting considerable variability in AI infectiousness between and within partnerships over time. AI may substantially increase HIV transmission risk even if the infected partner is receiving HAART; however, predictions are highly sensitive to infectiousness assumptions based on viral load.

Conclusions: Unprotected AI is a high-risk practice for HIV transmission, probably with substantial variation in infectiousness. The significant heterogeneity between infectiousness estimates means that pooled AI HIV transmission probabilities should be used with caution. Recent reported rises in AI among heterosexuals suggest a greater understanding of the role AI plays in heterosexual sex lives may be increasingly important for HIV prevention.

Figures

Figure 1
Figure 1
Forest plot of studies estimating HIV transmission probabilities for AI expressing risk as (a) per-act and (b) per-partner. For crude estimates (unfilled boxes), the size of box represents relative study sample size. Adjusted estimate (filled Rhombus), Crude estimate based on x number of seroconverting partners among n couples with an infected index partner (open square), Summary estimate (filled squre)
Figure 2
Figure 2
Relation between per-partner HIV transmission risk (cumulative probability of HIV transmission) and the number of sexual acts with an HIV infected partner, using our summary per-act URAI estimate of 1.4% (95% CI 0.2–2.5). The intersection between the modelled per-partner HIV transmission risk (y-axis) and our meta-analytic per-partner combined URAI–UIAI summary estimates (plotted as horizontal lines) predicts the required average number of acts per partnership (x-axis), under our model assumptions (see ‘Methods’ section). Adjusted estimates control for exposures due to multiple partners and crude estimates do not. (a) All acts assumed to be URAI; (b) 50% acts URAI, 50% acts UIAI, assuming that per-act UIAI has the same HIV transmission probability as penile–vaginal intercourse (summary estimate of per-act penile–vaginal intercourse, male-to-female transmission for developing countries: 0.3%; (c) as for (b) but UIAI HIV transmission probability is 0.6%. Competing risk from UIAI increases the total number of unprotected acts necessary for transmission per partnership only by relatively modest amounts, especially when the increase in transmission probability of UIAI compared with VI is large, because UIAI infectiousness becomes closer to that of URAI.
Figure 3
Figure 3
Relation between per-partner HIV risk (cumulative probability of HIV transmission) and the number of all sexual acts (whether penile–vaginal or penile–anal) that uninfected MSM or heterosexual women are exposed to with HIV-infected men, exploring the impact of different frequencies of URAI within the partnership (if in a monogamous HIV discordant relationship) or among all sexual HIV exposures that an uninfected individual encounters. Frequency of sexual acts involving URAI: 0–20% represent ranges for women in heterosexual partnerships, with the remainder of sexual exposures assumed to be penile–vaginal; 50% represents MSM partnerships where each partner practises URAI and UIAI equally often; 100% represents MSM where the seronegative partner is always receptive. Scenario (a) represents the impact of URAI on per-partner HIV risk assuming a constant per-act probability for URAI (1.4%, Table 1) and for penile–vaginal intercourse (summary estimate of per-act penile–vaginal intercourse, male-to-female transmission for developing countries: 0.3%; we assume, in the absence of per-act HIV estimates for UIAI identified by our review, that HIV transmission probability is the same as for female-to-male penile–vaginal intercourse). Scenario (b) uses Function 1 to investigate impact of HAART, predicting per-partner HIV risk within a discordant couple where the index male has successful viral suppression due to HAART. Scenario (c) investigates the same, by using Function 2 (note change of y-axis scale). Scenarios (d) and (e) use Function 2 (separating graphs for women and MSM for clarity), additionally including viral rebound as a result of treatment failure for a proportion of the duration of exposure. The derived relationship between URAI infectiousness and plasma viral load calculated in Function 2 is illustrated in Supplementary Figure S3 (available as Supplementary data at IJE online).

References

    1. Gisselquist D, Potterat JJ, Brody S. Running on empty: sexual co-factors are insufficient to fuel Africa’s turbocharged HIV epidemic. Int J STD AIDS. 2004;15:442–52.
    1. Gisselquist D, Rothenberg R, Potterat J, Drucker E. HIV infections in sub-Saharan Africa not explained by sexual or vertical transmission. Int J STD AIDS. 2002;13:657–66.
    1. Brody S, Potterat JJ. Assessing the role of anal intercourse in the epidemiology of AIDS in Africa. Int J STD AIDS. 2003;14:431–36.
    1. Kloos H, Mariam DH. Some neglected and emerging factors in HIV transmission in Ethiopia. Ethiop Med J. 2007;45:103–7.
    1. Smith LB, Adler NE, Tschann JM. Underreporting sensitive behaviors: the case of young women’s willingness to report abortion. Health Psychol. 1999;18:37–43.
    1. Halperin DT. Heterosexual anal intercourse: prevalence, cultural factors, and HIV infection and other health risks, Part I. AIDS Patient Care STDS. 1999;13:717–30.
    1. Van Damme L, Ramjee G, Alary M, et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet. 2002;360:971–77.
    1. Cooper ER, Charurat M, Mofenson L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002;29:484–94.
    1. Reynolds S, Makumbi F, Kagaayi J, et al. Uganda: 16th Conference on Retroviruses and Opportunistic Infections; ART reduced the rate of sexual transmission of HIV among HIV-discordant couples in rural Rakai. Montreal, Abstract 52a, 2009.
    1. Sullivan P, Kayitenkore K, Chomba E, et al. Reduction of HIV transmission risk and high risk sex while prescribed ART: results from discordant couples in Rwanda and Zambia, 16th Conference on Retroviruses and Opportunistic Infections. Montreal, Abstract 52b, 2009.
    1. Bezemer D, de Wolf F, Boerlijst MC, et al. A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy. AIDS. 2008;22:1071–77.
    1. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008–12.
    1. Boily MC, Baggaley RF, Wang L, et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis. 2009;9:118–29.
    1. Gazzard BG, Shanson DC, Farthing C, et al. Clinical findings and serological evidence of HTLV-III infection in homosexual contacts of patients with AIDS and persistent generalised lymphadenopathy in London. Lancet. 1984;2:480–83.
    1. Flateby G, Eskild A, Brekke T, Moi H. Steady sexual relationship with an HIV-positive partner and the progression rate to AIDS. AIDS. 1996;10:1749–51.
    1. Rottingen JA, Garnett GP. The epidemiological and control implications of HIV transmission probabilities within partnerships. Sex Transm Dis. 2002;29:818–27.
    1. Wilson DP, Law MG, Grulich AE, Cooper DA, Kaldor JM. Relation between HIV viral load and infectiousness: a model-based analysis. Lancet. 2008;372:314–20.
    1. Abu-Raddad LJ, Boily MC, Self S, Longini IM., Jr Analytic insights into the population level impact of imperfect prophylactic HIV vaccines. J Acquir Immune Defic Syndr. 2007;45:454–67.
    1. Modjarrad K, Chamot E, Vermund SH. Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression. AIDS. 2008;22:2179–85.
    1. Salomon JA, Hogan DR. Evaluating the impact of antiretroviral therapy on HIV transmission. AIDS. 2008;22(Suppl. 1):S149–59.
    1. Fraser C, Hollingsworth TD, Chapman R, de Wolf F, Hanage WP. Variation in HIV-1 set-point viral load: epidemiological analysis and an evolutionary hypothesis. Proc Natl Acad Sci USA. 2007;104:17441–46.
    1. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. New England J Med. 2000;342:921–29.
    1. Fideli US, Allen SA, Musonda R, et al. Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Res Human Retroviruses. 2001;17:901–10.
    1. DeGruttola V, Seage GR, 3rd, Mayer KH, Horsburgh CR., Jr Infectiousness of HIV between male homosexual partners. J Clin Epidemiol. 1989;42:849–56.
    1. Vittinghoff E, Douglas J, Judson F, McKirnan D, MacQueen K, Buchbinder SP. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol. 1999;150:306–11.
    1. Halperin DT, Shiboski SC, Palefsky SC, Padian NS. High level of HIV-1 infection from anal intercourse: a neglected risk factor in heterosexual AIDS prevention. Int Conf AIDS. [abstract ThPeC7438], 7–12 July 2002, 14
    1. Leynaert B, Downs AM, de Vincenzi I. Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection. European Study Group on Heterosexual Transmission of HIV. Am J Epidemiol. 1998;148:88–96.
    1. Cheingsong-Popov R, Weiss RA, Dalgleish A, et al. Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain. Lancet. 1984;2:477–80.
    1. Nicolosi A, Correa Leite ML, Musicco M, Arici C, Gavazzeni G, Lazzarin A. The efficiency of male-to-female and female-to-male sexual transmission of the human immunodeficiency virus: a study of 730 stable couples. Italian Study Group on HIV Heterosexual Transmission. Epidemiology. 1994;5:570–75.
    1. Weller IV, Carne CA, Sattentau Q, et al. Human immunodeficiency virus (HIV) infection in the regular sexual partners of homosexual men with AIDS and persistent generalised lymphadenopathy. J Med Virol. 1987;22:91–98.
    1. Coates RA, Calzavara LM, Read SE, et al. Risk factors for HIV infection in male sexual contacts of men with AIDS or an AIDS-related condition. Am J Epidemiol. 1988;128:729–39.
    1. Goldsmith JM, Kalish SB, Ostrow DG, et al. Antibody to human lymphotropic virus type III: immunologic status of homosexual contacts of patients with the acquired immunodeficiency syndrome and the acquired immunodeficiency-related complex. Sex Transm Dis. 1987;14:44–47.
    1. Osmond D, Bacchetti P, Chaisson RE, et al. Time of exposure and risk of HIV infection in homosexual partners of men with AIDS. Am J Public Health. 1988;78:944–48.
    1. Giesecke J, Ramstedt K, Granath F, Ripa T, Rado G, Westrell M. Partner notification as a tool for research in HIV epidemiology: behaviour change, transmission risk and incidence trends. AIDS. 1992;6:101–7.
    1. Kaplan EH. Modeling HIV infectivity: must sex acts be counted? J Acquir Immune Defic Syndr. 1990;3:55–61.
    1. Palenicek J, Fox R, Margolick J, et al. Longitudinal study of homosexual couples discordant for HIV-1 antibodies in the Baltimore MACS Study. J Acquir Immune Defic Syndr. 1992;5:1204–11.
    1. Seage GR, 3rd, Mayer KH, Horsburgh CR., Jr Risk of human immunodeficiency virus infection from unprotected receptive anal intercourse increases with decline in immunologic status of infected partners. Am J Epidemiol. 1993;137:899–908.
    1. Porco TC, Martin JN, Page-Shafer KA, et al. Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS. 2004;18:81–88.
    1. Samuel MC, Mohr MS, Speed TP, Winkelstein W. Infectivity of HIV by anal and oral intercourse among homosexual men. Estimates from a prospective study in San Francisco. In: Kaplan EH, Brandeau ML, editors. Modeling the AIDS Epidemic: Planning, Policy and Prevention. New York: Raven Press; 1994. pp. 423–38.
    1. Hollingsworth TD, Anderson RM, Fraser C. HIV-1 transmission, by stage of infection. J Infect Dis. 2008;198:687–93.
    1. Powers KA, Poole C, Pettifor AE, Cohen MS. Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. Lancet Infect Dis. 2008;8:553–63.
    1. Vernazza P, Hirschel B, Bernasconi E, Flepp M. HIV transmission under highly active antiretroviral therapy. Lancet. 2008;372:1806–7; author reply 7.
    1. Lazzarin A, Saracco A, Musicco M, Nicolosi A. Man-to-woman sexual transmission of the human immunodeficiency virus. Risk factors related to sexual behavior, man’s infectiousness, and woman’s susceptibility. Italian Study Group on HIV Heterosexual Transmission. Arch Intern Med. 1991;151:2411–16.
    1. Mayer KH, Anderson DJ. Heterosexual HIV transmission. Infect Agents Dis. 1995;4:273–84.
    1. Silverman BG, Gross TP. Use and effectiveness of condoms during anal intercourse. A review. Sex Transm Dis. 1997;24:11–17.
    1. Scott GR. Genital herpes: audit of cases referred by general practitioners to a department of genito-urinary medicine. Br J Clin Pract. 1992;46:256–57.
    1. Nicolosi A, Correa Leite ML, Musicco M, Arici C, Gavazzeni G, Lazzarin A. The efficiency of male-to-female and female-to-male sexual transmission of the human immunodeficiency virus: a study of 730 stable couples. Italian Study Group on HIV Heterosexual Transmission. Epidemiology. 1994;5:570–75.
    1. Seidlin M, Vogler M, Lee E, Lee YS, Dublin N. Heterosexual transmission of HIV in a cohort of couples in New York City. AIDS. 1993;7:1247–54.
    1. Chamberland ME, Dondero TJ. Heterosexually acquired infection with HIV: a view from the III International Conference on AIDS. Ann Intern Med. 1987;107:763–66.
    1. Padian N, Marquis L, Francis DP, et al. Male-to-female transmission of human immunodeficiency virus. JAMA. 1987;258:788–90.
    1. Belec L, Dupre T, Prazuck T, et al. Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection. J Infect Dis. 1995;172:691–97.
    1. Levy JA. The transmission of HIV and factors influencing progression to AIDS. Am J Med. 1993;95:86–100.
    1. Baggaley RF, White RG, Boily MC. Systematic review of orogenital HIV-1 transmission probabilities. Int J Epidemiol. 2008;37:1255–65.
    1. Frost DM, Stirratt MJ, Ouellette SC. Understanding why gay men seek HIV-seroconcordant partners: intimacy and risk reduction motivations. Cult Health Sex. 2008;10:513–27.
    1. Davies PM, Simpson P. On male homosexual prostitution and HIV. In: Aggleton P, Davies PM, Hart G, editors. AIDS: Individual, Cultural and Policy Dimensions. London: Falmer Press; 1990.
    1. Aral SO, Patel DA, Holmes KK, Foxman B. Temporal trends in sexual behaviors and sexually transmitted disease history among 18- to 39-year-old Seattle, Washington, residents: results of random digit-dial surveys. Sexually Trans Dis. 2005;32:710–17.
    1. Baldwin JI, Baldwin JD. Heterosexual anal intercourse: an understudied, high-risk sexual behavior. Arch Sexual Behav. 2000;29:357–73.
    1. Friedman SR, Flom PL, Kottiri BJ, et al. Prevalence and correlates of anal sex with men among young adult women in an inner city minority neighborhood. AIDS. 2001;15:2057–60.
    1. Lewis DK, Watters JK, Case P. The prevalence of high-risk sexual behavior in male intravenous drug users with steady female partners. Am J Public Health. 1990;80:465–66.
    1. Gross M, Holte SE, Marmor M, Mwatha A, Koblin BA, Mayer KH. Anal sex among HIV-seronegative women at high risk of HIV exposure. The HIVNET Vaccine Preparedness Study 2 Protocol Team. J Acquir Immune Defic Syndr. 2000;24:393–98.
    1. Leichliter JS, Chandra A, Liddon N, Fenton KA, Aral SO. Prevalence and correlates of heterosexual anal and oral sex in adolescents and adults in the United States. J Infect Dis. 2007;196:1852–59.
    1. Satterwhite CL, Kamb ML, Metcalf C, et al. Changes in sexual behavior and STD prevalence among heterosexual STD clinic attendees: 1993–1995 versus 1999–2000. Sex Transmit Dis. 2007;34:815–19.
    1. Mosher WD, Chandra A, Jones J. Sexual behavior and selected health measures: men and women 15-44 years of age, United States, 2002. Adv Data. 2005;15:1–55.
    1. Johnson AM, Mercer CH, Erens B, et al. Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours. Lancet. 2001;358:1835–42.
    1. Boily MC, Baggaley RF, Masse B. The role of heterosexual anal intercourse for HIV transmission in developing countries: are we ready to draw conclusions? Sex Transm Infect. 2009;85:408–10.
    1. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373:48–57.
    1. Cohen MS, Gay C, Kashuba AD, Blower S, Paxton L. Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1. Ann Intern Med. 2007;146:591–601.
    1. Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS. 2009;23:1397–404.
    1. Cutler B, Justman J. Vaginal microbicides and the prevention of HIV transmission. Lancet Infect Dis. 2008;8:685–97.
    1. Skoler-Karpoff S, Ramjee G, Ahmed K, et al. Efficacy of carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372:1977–87.
    1. Buve A. Microbicide trials. 16th Conference on Retroviruses and Opportunistic Infections. Montreal: Abstract 121; 2009.
    1. Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101–29.
    1. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Br Med J. 2003;327:557–60.
    1. Laumann E, Gagnon JH, Michael RT, Michaels S. The Social Organization of Sexuality. Chicago: University of Chicago Press; 1994.
    1. Flannery D, Ellingson L, Votaw KS, Schaefer EA. Anal intercourse and sexual risk factors among college women, 1993–2000. Am J Health Behav. 2003;27:228–34.
    1. Houston AM, Fang J, Husman C, Peralta L. More than just vaginal intercourse: anal intercourse and condom use patterns in the context of “main” and “casual” sexual relationships among urban minority adolescent females. J Pediatr Adolesc Gynecol. 2007;20:299–304.
    1. Tian LH, Peterman TA, Tao G, et al. Heterosexual anal sex activity in the year after an STD clinic visit. Sex Trans Dis. 2008;35:905–9.
    1. Karim SS, Ramjee G. Anal sex and HIV transmission in women. Am J Public Health. 1998;88:1265–66.
    1. Matasha E, Ntembelea T, Mayaud P, et al. Sexual and reproductive health among primary and secondary school pupils in Mwanza, Tanzania: need for intervention. AIDS Care. 1998;10:571–82.
    1. Sallah ED, Grunitzky-Bekele M, Bassabi K, et al. [Sexual behavior, knowledge and attitudes to AIDS and sexually transmitted diseases of students at the University of Benin (Togo)] Sante. 1999;9:101–19.
    1. Fonck K, Kaul R, Kimani J, et al. A randomized, placebo-controlled trial of monthly azithromycin prophylaxis to prevent sexually transmitted infections and HIV-1 in Kenyan sex workers: study design and baseline findings. Int J STD AIDS. 2000;11:804–11.
    1. Ramjee G, Gouws E. Prevalence of HIV among truck drivers visiting sex workers in KwaZulu-Natal, South Africa. Sex Transm Dis. 2002;29:44–49.
    1. Ferguson A, Morris C. Assessing the role of anal intercourse in the epidemiology of AIDS in Africa. Int J STD AIDS. 2003;14:856.
    1. Lane T, Pettifor A, Pascoe S, Fiamma A, Rees H. Heterosexual anal intercourse increases risk of HIV infection among young South African men. AIDS. 2006;20:123–25.
    1. Schwandt M, Morris C, Ferguson A, Ngugi E, Moses S. Anal and dry sex in commercial sex work, and relation to risk for sexually transmitted infections and HIV in Meru, Kenya. Sex Transm Infect. 2006;82:392–96.
    1. Subramanian T, Gupte MD, Paranjape RS, et al. HIV, sexually transmitted infections and sexual behaviour of male clients of female sex workers in Andhra Pradesh, Tamil Nadu and Maharashtra, India: results of a cross-sectional survey. AIDS. 2008;22(Suppl. 5):S69–79.
    1. Munro HL, Pradeep BS, Jayachandran AA, et al. Prevalence and determinants of HIV and sexually transmitted infections in a general population-based sample in Mysore district, Karnataka state, southern India. AIDS. 2008;22(Suppl. 5):S117–25.
    1. Kalichman SC, Simbayi LC, Cain D, Jooste S. Heterosexual anal intercourse among community and clinical settings in Cape Town, South Africa. Sex Transm Infect. 2009;85:411–15.
    1. Padian NS, Marquis L, Francis DP, et al. Male-to-female transmission of human immunodeficiency virus. JAMA. 1987;258:788–90.
    1. Osmond D, Bacchetti P, Chaisson RE, et al. Time of exposure and risk of HIV infection in homosexual partners of men with AIDS. Am J Public Health. 1988;78:944–48.
    1. Grant RM, Wiley JA, Winkelstein W. Infectivity of the human immunodeficiency virus: estimates from a prospective study of homosexual men. J Infect Dis. 1987;156:189–93.
    1. Seage GR, Mayer KH, Horsburgh CRJ. Risk of human immunodeficiency virus infection from unprotected receptive anal intercourse increases with decline in immunologic status of infected partners. Am J Epidemiol. 1993;137:899–908.
    1. Porco TC, Martin JN, Page-Shafer KA, et al. Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS. 2004;18:81–88.
    1. May RM, Anderson RM. Transmission dynamics of HIV infection. Nature. 1987;326:137–42.
    1. DeGruttola V, Seage GR, 3rd, Mayer K, Horsburgh CR., Jr . In: Program and abstracts of the 4th International Conference on AIDS. Stockholm: Swedish Ministry of Health and Social Affairs; 1988. Infectivity of HIV in homosexual partners, abstract 4112.
    1. Ahlgren DJ, Gorny MK, Stein AC. Model-based optimization of infectivity parameters: a study of the early epidemic in San Francisco. J Acquir Immune Defic Syndr. 1990;3:631–43.
    1. Eisenberg B. The effect of variable infectivity on the risk of HIV infection. Stat Med. 1991;10:131–39.
    1. Jacquez JA, Koopman JS, Simon CP, Longini IM., Jr Role of the primary infection in epidemics of HIV infection in gay cohorts. J Acquir Immune Defic Syndr. 1994;7:1169–84.
    1. Rapatski BL, Suppe F, Yorke JA. HIV epidemics driven by late disease stage transmission. J Acquired Immune Deficiency Syndromes. 2005;38:241–53.
    1. Weber JN, McCreaner A, Berrie E, et al. Factors affecting seropositivity to human T cell lymphotropic virus type III (HTLV-III) or lymphadenopathy associated virus (LAV) and progression of disease in sexual partners of patients with AIDS. Genitourin Med. 1986;62:177–80.
    1. Ozturk GE, Kohler PF, Horsburgh CR, Jr, Kirkpatrick CH. The significance of antilymphocyte antibodies in patients with acquired immune deficiency syndrome (AIDS) and their sexual partners. J Clin Immunol. 1987;7:130–39.
    1. Goedert JJ, Eyster ME, Biggar RJ, Blattner WA. Heterosexual transmission of human immunodeficiency virus: association with severe depletion of T-helper lymphocytes in men with hemophilia. AIDS Res Hum Retroviruses. 1987;3:355–61.
    1. Johnson AM, Petherick A, Davidson SJ, et al. Transmission of HIV to heterosexual partners of infected men and women. AIDS. 1989;3:367–72.
    1. de Vincenzi I. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV. N Engl J Med. 1994;331:341–46.
    1. Guimaraes MD, Munoz A, Boschi Pinto C, Castilho EA. HIV infection among female partners of seropositive men in Brazil. Am J Epidemiol. 1995;142:538–47.
    1. Nagachinta T, Duerr A, Suriyanon V, et al. Risk factors for HIV-1 transmission from HIV-seropositive male blood donors to their female partners in northern Thailand. AIDS. 1997;11:1765–72.
    1. Padian NS, Shiboski SC, Glass SO, Vittinghoff E. Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: results from a ten-year study. Am J Epidemiol. 1997;146:350–57.
    1. Panda S, Chatterjee A, Bhattacharya SK, et al. Transmission of HIV from injecting drug users to their wives in India. Int J STD AIDS. 2000;11:468–73.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere